You are here: Home Newsroom News Item Boots Online Doctor launches new specialist medical cannabis service to support patients living with long-term health conditions

Boots Online Doctor launches new specialist medical cannabis service to support patients living with long-term health conditions

16 November 2026
News Healthcare
  • Boots Online Doctor launches SureLeaf, a specialist doctor-led medical cannabis service for people living with eligible chronic pain conditions, generalised anxiety disorder or insomnia 

  • The service offers eligible patients another treatment option where conventional treatments have not provided adequate symptom relief, supported by specialist clinical assessment and care 

  • To help strengthen the real-world evidence for medical cannabis, Boots is exploring a collaborative research programme with the University of Nottingham examining patient outcomes, prescribing practices and experience in the treatment of chronic pain 

Boots Online Doctor today announces the launch of SureLeaf, a specialist medical cannabis service giving eligible patients living with chronic pain, generalised anxiety disorder or insomnia access to consultant-led assessment, treatment and ongoing clinical care. 

The new service expands the range of specialist healthcare available through Boots Online Doctor, giving eligible patients another treatment option to consider and greater access to clinical expertise. 

Jamie Kerruish, Chief Healthcare Officer, Boots, said: “At Boots, we’re committed to making healthcare more accessible and helping people find the right support for their individual needs. Millions of people live with ongoing pain and for some, conventional treatments do not provide adequate symptom relief. This can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy. Medical cannabis is a specialist area of healthcare and, through SureLeaf, we’re giving eligible patients another treatment option to consider, supported by clinical expertise and robust ongoing care. Ultimately, it’s about helping people explore appropriate options that could help them better manage their symptoms and improve their quality of life.” 

SureLeaf brings together specialist consultants, multidisciplinary clinical oversight and ongoing patient monitoring throughout treatment. Patients aged 25 or over with an eligible condition can begin their assessment online, with suitability reviewed by the clinical team before progressing to a video consultation with a consultant in the relevant medical specialty who is on the General Medical Council Specialist Register. 

Any proposed prescription will be independently reviewed by a multidisciplinary clinical team that includes a second, independent consultant, before treatment begins. Patients must have previously tried conventional treatments without achieving adequate symptom relief. 

Once treatment begins, patients will receive ongoing clinical support and monitoring, including an initial review after 28 days followed by reviews at least every three months. Validated questionnaires will be used throughout treatment to assess relevant areas including quality of life, pain, anxiety, sleep and mood, helping clinicians monitor the effectiveness of treatment.

Dr David Gwynne, Medical Director, Boots Online Doctor, said: “Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis. SureLeaf has therefore been designed with strong clinical safeguards and specialist oversight at every stage, so treatment is only considered for patients where it is clinically appropriate. Our priority is to ensure patients receive responsible, clinically led care, from their initial specialist assessment through to ongoing monitoring and review once treatment begins.”

Alongside the launch, Boots and the University of Nottingham are exploring a collaborative research programme to build on the existing real-world evidence and understanding of medical cannabis in chronic pain management. 

The work would build on the existing partnership between the two organisations, which is based on a shared commitment to improve patient care through evidence led innovation and aims to help inform future clinical practice, support responsible service development and contribute to the broader understanding of the role medical cannabis could play.   

SureLeaf will operate as a private healthcare service through Boots Online Doctor and will support people living with the following eligible conditions: 

  • Chronic pain conditions including chronic primary and neuropathic pain, fibromyalgia, complex regional pain syndrome, chronic back or neck pain, osteoarthritis, rheumatoid arthritis, sciatica, peripheral neuropathy, trigeminal neuralgia, phantom limb pain, chronic migraine, endometriosis-related pelvic pain and chronic abdominal or pancreatic pain 

  • Generalised anxiety disorder 

  • Insomnia disorder 

Further information, including full eligibility criteria and how to access the service, is available on the dedicated service page here. 

News

What’s new at Boots? Find out the latest updates from the UK’s largest pharmacy-led health and beauty chain – from new products and services to important business developments.

xx

Features

Take a closer look at our team members and the work they do, learn more about our corporate social responsibility initiatives and see how we work behind the scenes.

xx

About Boots:   

Boots is the UK’s leading health, wellness and beauty retailer with over 51,000 team members and over 1,800 stores, ranging from local community pharmacies to large health and beauty destinations.*  

Boots serves its customers and patients for life as the leading provider of healthcare on the high street, offering accessible wellness solutions and as the UK’s number one beauty destination. It offers an unrivalled depth and breadth of products, which incorporates its extensive own brand range and innovative portfolio of brands, including No7, the UK’s No1 skincare brand, Soap & Glory, Liz Earle Beauty and Sleek MakeUP.    

Boots is part of The Boots Group, which is a trusted leader in healthcare, pharmacy and retail.  More company information is available on boots-uk.com.   

*Figures accurate as of 28 February 2026